Skip to content
Clinical Trials – home

SODIUM NITROPRUSSIDE DIHYDRATE: A Comprehensive Guide for Patients

0 / 2
trials open to patients / all trials
1+
Countries

In short

Sodium Nitroprusside Dihydrate is a medication being studied in clinical trials for its potential effects on heart health and microvascular function. These trials are investigating how this drug may benefit patients with conditions such as heart failure with preserved ejection fraction (HFpEF) and vasospastic angina. The studies aim to evaluate the drug's impact on peripheral microvascular function and its potential to improve symptoms and quality of life for patients with these cardiovascular conditions.

At a glance

Drug Name
Sodium Nitroprusside Dihydrate
Conditions Studied
Heart failure with preserved ejection fraction (HFpEF), Vasospastic angina
Administration Methods
Solution for infusion, Topical application via iontophoresis
Main Study Objectives
Evaluate effects on peripheral microvascular function, Assess impact on quality of life and symptoms
Key Measurement Techniques
Laser speckle contrast analysis (LASCA), EndoPAT
Other Medications Studied
Empagliflozin, Vericiguat
Patient Assessments
Quality of life questionnaires, Angina burden, Major adverse cardiac events

What is Sodium Nitroprusside Dihydrate?

Sodium Nitroprusside Dihydrate, also known by its brand name NIPRUSS, is a medication used in various medical settings. It belongs to a class of drugs called vasodilators, which means it helps to widen blood vessels. The term "dihydrate" refers to the chemical structure of the compound, which includes two water molecules.

Medical Uses

Sodium Nitroprusside Dihydrate is primarily used in the following medical situations:

  • Hypertensive Crisis: It's used to quickly lower dangerously high blood pressure.
  • Controlled Hypotension: During certain surgical procedures, it may be used to lower blood pressure in a controlled manner.
  • Heart Failure: It can help improve blood flow in patients with severe heart failure.
  • Vasospastic Angina: Recent clinical trials are exploring its use in patients with vasospastic angina, a condition where coronary arteries spasm and cause chest pain.

How It Works

Sodium Nitroprusside Dihydrate works by relaxing the smooth muscles in your blood vessel walls. This causes the blood vessels to dilate or widen, which reduces blood pressure and improves blood flow throughout the body. In medical terms, it's called a nitrovasodilator, meaning it releases nitric oxide in the body, which is the molecule responsible for relaxing blood vessels.

Administration

Sodium Nitroprusside Dihydrate is typically administered in the following ways:

  • Intravenous Infusion: In hospital settings, it's usually given as a continuous infusion into a vein.
  • Iontophoresis: In some clinical trials, a diluted form (0.1% concentration) is being administered through a process called iontophoresis. This is a technique that uses a small electric current to deliver the medication through the skin.

Current Clinical Trials

Sodium Nitroprusside Dihydrate is currently being studied in clinical trials for new potential uses:

  • Vasospastic Angina: A study is investigating its effects on microvascular function in patients with vasospastic angina. Researchers are using a technique called laser speckle contrast analysis (LASCA) to measure how well small blood vessels in the skin respond to the medication.
  • Heart Failure with Preserved Ejection Fraction (HFpEF): Another study is looking at how Sodium Nitroprusside Dihydrate affects blood flow in patients with this specific type of heart failure.

Potential Side Effects

As with any medication, Sodium Nitroprusside Dihydrate can cause side effects. Some potential side effects include:

  • Excessive lowering of blood pressure
  • Headache
  • Nausea
  • Dizziness
  • Flushing (redness of the skin)

In rare cases, more serious side effects can occur. Always inform your healthcare provider of any unusual symptoms.

Precautions and Considerations

Before using Sodium Nitroprusside Dihydrate, it's important to consider the following:

  • Medical History: Inform your doctor about any pre-existing medical conditions, especially liver or kidney problems.
  • Pregnancy and Breastfeeding: The safety of this medication during pregnancy or while breastfeeding is not fully established. Discuss with your doctor if you are pregnant or planning to become pregnant.
  • Other Medications: Tell your doctor about all other medications you're taking, as Sodium Nitroprusside Dihydrate can interact with certain drugs.
  • Monitoring: When receiving this medication, your blood pressure and heart rate will be closely monitored.

Questions people often ask

Conditions where Sodium Nitroprusside Dihydrate is being studied

Each condition opens its own overview and trial list

Trials with Sodium Nitroprusside Dihydrate

Recruiting trials first

See all 2 →
Quick filters
  • Participants:Adults
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).